PLAU and neoplasm: Tumor-enriched proteases (such as matrix metalloproteinase-2 [MMP2], MMP9, and urokinase plasminogen activator [uPA]3) can cleave the linker and release hemagglutinin (HA)-tagged IL-15 within the TME.